![Servier - Moved by you..]({"type":"image" , "src" : "/sda/112354/JournalAd-Servier-5s.gif"})
References
- Sabina RL. Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation. Neurol Clin 2000; 18: 185–94.
- Skyllouriotis ML, Marx M, Bittner RE, Skyllouriotis P, Gross M, Wimmer M. Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism symdrome. Pediatr Neurol 1997; 17: 61–6.
- Scholte HR, Busch HFM, Luyt-Houwen IEM. Familial AMP deaminase deficiency with skeletal muscle type I atro-phy and fatal cardiomyopathy. J Inher Metab Dis 1981; 4: 169–70.
- Stöllberger C, Finsterer J, Blazek G. Left ventricular hyper-trabeculation/noncompaction and association with addi-tional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90: 28–31.
- Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL. Genetic and other determinants of AMP deaminase activ-ity in healthy adult skeletal muscle. J Appl Physiol 1998; 85: 1273–8.
- Abe M, Higuchi I, Morisaki H, Morisaki T, Osame M. Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient. Neuromus-cul Disord 2000; 10: 472–7.
- De Ruiter CJ, May AM, van Engelen BGM, Wevers RA, Steenbergern-Spanjers GC, de Haan A. Muscle function during repetitive moderate-intensity muscle contractions in myoadenylate deaminase-deficient Dutch subjects. Clin Sci 2002; 102: 531–9.
- Rico-Sanz J, Rankinen T, Joanisse DR, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 polymorphism in the HERITAGE family study. Physiol Genomics 2003; 14: 161–6.
- Fishbein WN. Primary, secondary, and coincidental types of myoadenylate deaminase deficiency. Ann Neurol 1999; 45: 547–8.
- Verzijl HTFM, van Engelen BGM, Luyten JAFM, Steen-bergern GCH, van den Heuvel LPWJ, ter Laak HJ, Padberg GW, Wevers RA. Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol 1998; 44: 140–3.
- Fishbein WN. Myoadenylate deaminase. In: Encyclopedia of molecular medicine. John Wiley & Sons, New York, 2002; 3: 2187–90.
- Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inher Metab Dis 1997; 20: 186–92.
- Loh E, Rehbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Cir-culation 1999; 99: 1422–5.
- Wang X, Morisaki H, Sermsuvitayawong K, Mineo I, Toyama K, Ogasawara N, Mukai T, Morisaki T. Cloning and expression of cDNA encoding heart-type isioform of AMP deaminase. Gene 1997; 188: 285–90.
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.]({"type":"image" , "src" : "/sda/112392/Skyscraper_BristolMyersSquibb.jpg"})